2025年7月11日，Y-mAbs Therapeutics公司成功举行了年度股东大会。股东们对三项关键提案进行了投票表决。David N. Gill当选为Class I董事；PricewaterhouseCoopers LLP被批准为截至2025年12月31日财年的独立注册公共会计师事务所；此外，高管薪酬的咨询投票获得一致通过。 免责声明：本新闻基于美国证券交易委员会EDGAR系统发布的信息（参考号：0001104659-25-068099），由AI生成，仅供信息参考，不构成财务、投资或法律建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.